16689-14-8
Chemical Structure
L-Leucyl-L-Leucine methyl ester hydrobromide
Synonym(s): LLOMe hydrobromide; Leu-Leu methyl ester hydrobromide; H-Leu-Leu-OMe hydrobromide
- CAS No.: 16689-14-8
- Formula:C13H27BrN2O3
- Molecular Weight:339.27
IUPAC Name: methyl L-leucyl-L-leucinate hydrobromide
InChIKey: QIPBCIHWFATZOF-ACMTZBLWSA-N
SMILES: CC(C)C[C@@H](C(OC)=O)NC([C@H](CC(C)C)N)=O.[H]Br
Biological Activity: L-Leucyl-L-Leucine methyl ester (LLOMe) hydrobromide, a dipeptide condensation product of L-leucine methyl ester generated by human monocytes or polymorphonuclear leukocytes, selectively eliminates lymphocytes with cytotoxic potential. L-Leucyl-L-Leucine methyl ester hydrobromide also can induce endolysosomal pathway stress[1][2][3].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Leucyl-L-Leucine methyl ester hydrobromide | 99.69% | L-Leucyl-L-Leucine methyl ester (LLOMe) hydrobromide, a dipeptide condensation product of L-leucine methyl ester generated by human monocytes or polymorphonuclear leukocytes, selectively eliminates lymphocytes with cytotoxic potential. L-Leucyl-L-Leucine methyl ester hydrobromide also can induce endolysosomal pathway stress. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Leucyl-L-Leucine methyl ester hydrobromide (Standard) | ≥98% | L-Leucyl-L-Leucine methyl ester hydrobromide (Standard) is the analytical standard of L-Leucyl-L-Leucine methyl ester hydrobromide (HY-129905A). This product is intended for research and analytical applications. L-Leucyl-L-Leucine methyl ester (LLOMe) hydrobromide, a dipeptide condensation product of L-leucine methyl ester generated by human monocytes or polymorphonuclear leukocytes, selectively eliminates lymphocytes with cytotoxic potential. L-Leucyl-L-Leucine methyl ester hydrobromide also can induce endolysosomal pathway stress. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Thiele DL, et, al. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J Immunol. 1986 Feb 1;136(3):1038-48. [Content Brief]
- [2]. Thiele DL, et, al. Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc Natl Acad Sci U S A. 1990 Jan;87(1):83-7. [Content Brief]
- [3]. Kalogeropulou AF, et, al. Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity. Biochem J. 2020 Nov 27;477(22):4397-4423. [Content Brief]
